HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(188)Rhenium tin-colloid

therapeutic agent for rheumatoid arthritis

Also Known As:

188Re-tin-colloid

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Metals: 20694
  - Heavy Metals: 3207
    - Tin: 1235
      - (188)Rhenium tin-colloid: 2
    - Rhenium: 229
      - (188)Rhenium tin-colloid: 2
- Elements: 18681
  - Heavy Metals: 3207
    - Tin: 1235
      - (188)Rhenium tin-colloid: 2
    - Rhenium: 229
      - (188)Rhenium tin-colloid: 2
  - Transition Elements: 3
    - Rhenium: 229
      - (188)Rhenium tin-colloid: 2

Experts

1.	Chiang, Ping-Fang: 1 article (01/2019)
2.	Lin, Xi-Zhang: 1 article (01/2019)
3.	Luo, Tsai-Yueh: 1 article (01/2019)
4.	Peng, Cheng-Liang: 1 article (01/2019)
5.	Shih, Ying-Hsia: 1 article (01/2019)
6.	Weng, Mao-Feng: 1 article (01/2019)
7.	Cheon, G J: 1 article (06/2003)
8.	Jeong, J M: 1 article (06/2003)
9.	Lee, E B: 1 article (06/2003)
10.	Lee, Y J: 1 article (06/2003)

Related Diseases

1.	Rheumatoid Arthritis 06/01/2003 - "188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis." 06/01/2003 - "We have developed a 188Re-tin-colloid as a new radiopharmaceutical agent and investigated its efficacy and safety in patients with rheumatoid arthritis. " 06/01/2003 - "In conclusion, in this first study of radiation synovectomy using 188Re-tin-colloid for patients with rheumatoid arthritis, the treatment resulted in the improvement of arthritis and was well tolerated." 06/01/2003 - "Radiation synovectomy was performed using 188Re-tin-colloid in 22 knees from 21 rheumatoid arthritis patients refractory to intra-articular corticosteroid injection. "
2.	Arthritis (Polyarthritis) 06/01/2003 - "In conclusion, in this first study of radiation synovectomy using 188Re-tin-colloid for patients with rheumatoid arthritis, the treatment resulted in the improvement of arthritis and was well tolerated."
3.	Neoplasms (Cancer) 01/01/2019 - "Following the injection of 188Re-Tin-colloid micro-particles for 14 days, all BNL tumors in mice were regressed during the observation period. " 01/01/2019 - "The results of biodistribution showed that major radioactivity (188Re) of 188Re-Tin-colloid micro-particles (18.69 ± 4.28 %ID/g) remained at the tumor sites, compared with 188Re micro-particles (0.21 ± 0.12 %ID/g), 24 h post injection. " 01/01/2019 - "The micro-particles were injected into the tumor site subcutaneously in the BNL HCC-bearing mice with three treatment groups, normal saline, 188Re micro-particles, and 188Re-Tin-colloid micro-particles. "

Related Drugs and Biologics

1.	Radiopharmaceuticals
2.	Adrenal Cortex Hormones (Corticosteroids)
3.	Saline Solution

Related Therapies and Procedures

1.	Synovectomy